iCardiac acquires Longmont-based nSpire Health’s clinical-trials division

LONGMONT — The clinical-trials division of Longmont-based nSpire Health Inc. has been acquired by iCardiac Technologies, based in Rochester, N.Y.

iCardiac, a provider of cardiac safety assessment services to the pharmaceutical industry, has opened an office in Longmont to accommodate the project-management, data-management, customer-support, information-technology, technology-development and business-development teams that are joining iCardiac from nSpire Health.

Financial terms of the deal were not disclosed, and the acquisition is effective immediately.

Formed in late 2006 in Louisville after a team of private investors acquired Louisville-based Ferraris Respiratory, nSpire Health moved its headquarters to 74,800 square feet of leased space at 1830 Lefthand Circle in…